Intra-Cellular Therapies, Inc.
Total Trades
140
Buys
0
Sells
74
Largest Trade
N/A
Insiders
8
Institutional Funds
1
Inst. Value
$1K–$15K
Activist Filings
11
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| VAN NOSTRAND ROBERT L | Director | EXERCISE | $100K–$500K | 30K | $12.65 | Aug 12, 2022 |
| MARCUS JOEL S | Director | SELL | $500K+ | 10K | $59.22 | Aug 12, 2022 |
| MARCUS JOEL S | Director | EXERCISE | N/A | 14K | — | May 13, 2022 |
| MARCUS JOEL S | Director | SELL | $500K+ | 10K | $55.00 | May 13, 2022 |
| Neumann Mark | EVP | EXERCISE | $1M+ | 86K | $12.73 | Apr 8, 2022 |
| Neumann Mark | EVP | SELL | $1M+ | 86K | $64.37 | Apr 8, 2022 |
| RIGGS RORY B | Director | SELL | $1M+ | 227K | $60.10 | Mar 19, 2022 |
| MARCUS JOEL S | Director | SELL | $1M+ | 20K | $53.14 | Mar 10, 2022 |
| Durgam Suresh K. | Chief Medical Offi… | SELL | $100K–$500K | 8K | $56.28 | Mar 4, 2022 |
| Durgam Suresh K. | Chief Medical Offi… | EXERCISE | N/A | 8K | — | Feb 26, 2022 |
| Durgam Suresh K. | Chief Medical Offi… | SELL | $100K–$500K | 4K | $52.27 | Feb 26, 2022 |
| Neumann Mark | EVP | SELL | $100K–$500K | 8K | $52.21 | Feb 26, 2022 |
| Neumann Mark | EVP | EXERCISE | N/A | 8K | — | Feb 26, 2022 |
| Halstead Michael | EVP and General Co… | EXERCISE | N/A | 8K | — | Feb 26, 2022 |
| Halstead Michael | EVP and General Co… | SELL | $100K–$500K | 8K | $51.98 | Feb 26, 2022 |
| Hineline Lawrence J. | SVP of Finance CFO | SELL | $100K–$500K | 7K | $51.97 | Feb 26, 2022 |
| Hineline Lawrence J. | SVP of Finance CFO | EXERCISE | N/A | 7K | — | Feb 26, 2022 |
| Mates Sharon | Chairman | EXERCISE | N/A | 23K | — | Feb 26, 2022 |
| Mates Sharon | Chairman | SELL | $1M+ | 23K | $51.98 | Feb 26, 2022 |
| Durgam Suresh K. | Chief Medical Offi… | EXERCISE | N/A | 8K | — | Feb 24, 2022 |
| Durgam Suresh K. | Chief Medical Offi… | SELL | $100K–$500K | 4K | $55.29 | Feb 24, 2022 |
| Neumann Mark | EVP | EXERCISE | N/A | 11K | — | Feb 24, 2022 |
| Neumann Mark | EVP | SELL | $500K+ | 11K | $55.29 | Feb 24, 2022 |
| Halstead Michael | EVP and General Co… | EXERCISE | N/A | 11K | — | Feb 24, 2022 |
| Halstead Michael | EVP and General Co… | SELL | $500K+ | 11K | $55.40 | Feb 24, 2022 |
| Hineline Lawrence J. | SVP of Finance CFO | SELL | $500K+ | 10K | $55.40 | Feb 24, 2022 |
| Hineline Lawrence J. | SVP of Finance CFO | EXERCISE | N/A | 10K | — | Feb 24, 2022 |
| Mates Sharon | Chairman | EXERCISE | N/A | 28K | — | Feb 24, 2022 |
| Mates Sharon | Chairman | SELL | $1M+ | 28K | $55.39 | Feb 24, 2022 |
| Durgam Suresh K. | Chief Medical Offi… | SELL | $100K–$500K | 6K | $42.03 | Jan 20, 2022 |
| Durgam Suresh K. | Chief Medical Offi… | EXERCISE | N/A | 13K | — | Jan 12, 2022 |
| Durgam Suresh K. | Chief Medical Offi… | SELL | $100K–$500K | 7K | $40.76 | Jan 12, 2022 |
| Neumann Mark | EVP | EXERCISE | N/A | 21K | — | Jan 12, 2022 |
| Neumann Mark | EVP | SELL | $500K+ | 21K | $40.78 | Jan 12, 2022 |
| Halstead Michael | EVP and General Co… | SELL | $500K+ | 20K | $40.77 | Jan 12, 2022 |
| Halstead Michael | EVP and General Co… | EXERCISE | N/A | 20K | — | Jan 12, 2022 |
| Hineline Lawrence J. | SVP of Finance CFO | SELL | $500K+ | 20K | $40.76 | Jan 12, 2022 |
| Hineline Lawrence J. | SVP of Finance CFO | EXERCISE | N/A | 20K | — | Jan 12, 2022 |
| Mates Sharon | Chairman | SELL | $1M+ | 42K | $40.78 | Jan 12, 2022 |
| Mates Sharon | Chairman | EXERCISE | N/A | 42K | — | Jan 12, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 1 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $1K–$15K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Jun 5, 2025
0.0%
0 shares
SC 13G/A · Feb 7, 2025
2.5%
2.7M shares
SC 13G/A · Nov 12, 2024
10.5%
11.1M shares
SC 13G/A · Nov 8, 2024
5.9%
6.2M shares
SC 13G/A · Oct 24, 2024
5.9%
6.2M shares
JPMORGAN CHASE & CO. 13-2624428
SC 13G · Oct 10, 2024
5.0%
5.3M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
9.4%
9.1M shares
SC 13G/A · Jan 25, 2024
8.5%
8.2M shares
SC 13G/A · Feb 3, 2023
7.9%
7.4M shares
Wasatch Advisors LP 87-0319391
SC 13G/A · Jan 10, 2023
5.0%
4.7M shares
Wasatch Advisors, Inc. 87-0319391
SC 13G/A · Feb 10, 2022
10.1%
8.2M shares